Biktarvy, formally known as bictegravir sulfate, represents a potent single-tablet therapy for managing HIV infection. This formula combines three key antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It works by preventing the virus's ability to replicate within the body, remarkably decreasing the viral burden. For many in